HIF1A and neoplasm: In contrast, HIF-1α stability may depend on high levels of reactive oxygen species (ROS) in hypoxic cancer cells [25, 26], which can activate the NF-κB, TNF-α and STAT3 signaling pathways in inflammatory cells and tumor cells to release a variety of inflammatory cytokines involved in changes in the TME [27].